Technological Advancement Accelerating the Biological Imaging Reagents Market to Grow at 7.91% of CAGR by 2025

According to a new market research report published by Inkwood Research, The global artificial intelligence in healthcare market was valued at $1210 million in 2016 and is estimated to generate a net revenue of approximately $25.1 billion by 2025 growing at a CAGR of 40.07% during the forecast period 2017-2025.

According to a new market research report published by Inkwood Research, The global biological imaging reagents market is anticipated to grow from $ 13816 million in 2016 to $ 27584 million by 2025, at a CAGR of 7.91 % between 2016 and 2025.

Browse 45 market data Tables and 50 Figures spread through 135 Pages and in-depth TOC on “Biological Imaging Reagents Market Forecast 2017-2025.”

Growing demand for imaging technologies, Increased access to cutting-edge laser eye medication, Development of newer, targeted imaging agents and expansion of imaging technologies are boosting the growth of the global biological imaging reagents market.

Research and Development one of the fastest growing end-user segment
The Research and development market includes research, drug discovery and drug development. The research and development market demand is driven by novel radiopharmaceutical imaging reagents, which are developed for the drug discovery and development market. Increasing need for optical biologic detection technologies in genomics, proteomics, and cellular analysis applications are the key factors boosting the market for research and development.

Contrast Imaging holds the biggest share of the application market

The ultrasound (CEUS) imaging has been developed to envisage the micro-circulation in tissue and for the flow of blood in very small blood vessels. Ultrasound Doppler methods perform well in many situations for the flow assessment in relatively large blood vessels. However, for assessment of the microvasculature and perfusion measurements, the blood velocities are so low that they cannot be detected with ordinary, non-invasive Doppler techniques. In these situations, the use of an ultrasound contrast agent is necessary.

The United States holds the largest share in the North American region

Huge funding for life science-based research by government organizations has been a key growth driver of the market in the region. This can be depicted from the funds recommended by Federation of American Society for Experimental Biology (FASEB) in the U.S. The increasing demands of genetically modified organisms for crops production are increasing day by day in the U.S. In 2015, more than 40% of the global GMO crop market was captured by U.S. region. This increasing demand for GMO crops in the U.S. increased the market for Biological Imaging Reagents in U.S. region.

The major market players in the global biological imaging reagents market are Bayer healthcare pharmaceuticals, Bracco SPA, GE healthcare, Lantheus medical imaging inc, PerkinElmer INC.

The biological imaging reagents market report provides competitive landscapes, market drivers, trends, restraints, opportunities and challenges in this market. The report estimates the current size and the future growth potential of the market across diverse applications, technologies, verticals, types, and regions. The outlook of the report additionally comprises of mergers and acquisitions, strategies, product portfolios, agreements, partnerships and collaborations amongst the key players.

About Inkwood Research

Inkwood Research specializes in syndicated & customized research reports and consulting services.
Market intelligence studies with relevant fact-based research are customized across industry verticals including technology, automotive, chemicals, materials, healthcare, and energy with real comprehension acknowledging the business environments. Our geographical analysis comprises of North & South America, CEE, CIS, Middle East, Europe, Asia, and Africa.

Contact Us:
Inkwood Research
Tel : +1 857-302-4704